MedTrace Logo

Testing of Computer Aided Detection Software for Riverain Medical Group

NCT00906789 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2014-09-01

Study results available
· View outcomes & findings →

Summary

This is a clinical trial using retrospective data of two different software devices developed by Riverain Medical Group: Softview and OnGuard 5.0. The two studies will be run concurrently. Riverain Medical Group's computer systems are designed to assist radiologists in their identification of lung cancer on chest radiographs. The current machine received FDA Pre-Market Approval. This is to test two new software approaches.

Conditions

Interventions

BEHAVIORAL

Software

This is an observer performance study. Radiologists will interpret chest radiographs without and then with the Riverain software, both SoftView (TM) OnGuard (TM) CADe Software with be tested

Sponsors & Collaborators

  • Riverain Technologies

    collaborator INDUSTRY

  • Georgetown University

    lead OTHER

Principal Investigators

  • Matthew T. Freedman, MD, MBA · Georgetown University

  • Ben Lo, Ph.D. · Georgetown University

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00906789 on ClinicalTrials.gov